(Q36673674)

15 August 2017

Phase II study of viscum fraxini-2 in patients with advanced hepatocellular carcinoma (English)

1 reference

15 August 2017

hepatocellular carcinoma

1 reference

M Mabed

1

1 reference

15 August 2017

L El-Helw

series ordinal

2

1 reference

15 August 2017

S Shamaa

series ordinal

3

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

15 August 2017

5

1 reference

British Journal of Cancer

inferred from page(s)

published in

1 reference

15 August 2017

90

1 reference

15 August 2017

1

1 reference

15 August 2017

65-69

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6601463

15 August 2017

0 references

cites work

Mistletoe in cancer - a systematic review on controlled clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2395314

Clinical trials of HCC in Taiwan.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2395314

Phase II and pharmacokinetic study of paclitaxel therapy for unresectable hepatocellular carcinoma patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2395314

Treatment of hepatocellular carcinoma: too many options?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2395314

Reporting results of cancer treatment

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2395314

Tumor heterogeneity and drug resistance

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2395314

Phase II trial of mitoxantrone in patients with hepatocellular carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2395314

Effects of mistletoe (Viscum album L.) extracts on cultured tumor cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2395314

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2395314

Biochemical characterization of a component in extracts of Viscum album enhancing human NK cytotoxicity

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2395314

Increased secretion of tumor necrosis factors alpha, interleukin 1, and interleukin 6 by human mononuclear cells exposed to beta-galactoside-specific lectin from clinically applied mistletoe extract

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2395314

Overexpression of the MDR1 gene and P-glycoprotein in human hepatocellular carcinoma

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2395314

Nonparametric Estimation from Incomplete Observations

28 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601463

Demonstration of specifically sensitized lymphocytes in patients treated with an aqueous mistletoe extract (Viscum album L.)

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601463

Doxorubicin for unresectable hepatocellular carcinoma. A prospective study on the addition of verapamil

21 January 2018

1 reference

12 December 2020

A phase II trial of vindesine in hepatocellular cancer

1 reference

12 December 2020

Mediation of human NK-activity by components in extracts of Viscum album

1 reference

12 December 2020

Primary liver cancers in Japan

1 reference

12 December 2020

A phase II study of raltitrexed ('Tomudex') in patients with hepatocellular carcinoma

1 reference

12 December 2020

A phase 2 study of cisplatin in patients with hepatocellular carcinoma

1 reference

12 December 2020

The Anticyclic Timing of Leaf Senescence in the Parasitic Plant Viscum album Is Closely Correlated with the Selective Degradation of Sulfur-Rich Viscotoxins

1 reference

12 December 2020

Synergistic action of a plant rhamnogalacturonan enhancing antitumor cytotoxicity of human natural killer and lymphokine-activated killer cells: chemical specificity of target cell recognition

1 reference

12 December 2020

In vitro effects of mistletoe extracts and mistletoe lectins. Cytotoxicity towards tumor cells due to the induction of programmed cell death (apoptosis)

1 reference

12 December 2020

Botany of European mistletoe (Viscum album L.).

1 reference

12 December 2020

The surgical management of primary carcinoma of the liver

1 reference

12 December 2020

Potentiation of haemolysis by the combined action of phospholipase A and a basic peptide containing S-S-bonds (Viscotoxin B)

1 reference

12 December 2020

Doxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma. A prospective randomized trial

1 reference

12 December 2020

An overview on anticancer activities of the Viscum album extract Isorel

1 reference

12 December 2020

A Phase II trial of nolatrexed dihydrochloride in patients with advanced hepatocellular carcinoma

1 reference

12 December 2020

Phase II trial of chronic daily VP-16 administration in unresectable hepatocellular carcinoma (HCC)

1 reference

12 December 2020

Phase II study of high-dose ifosfamide in hepatocellular carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6601463

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference

15 August 2017

PubMed publication ID

14710208

1 reference